← Back to Clinical Trials
Recruiting NCT07042451

NCT07042451 An Evaluation of the Pink Cloud Application in Post- Treatment Substance Use Disorder Support

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07042451
Status Recruiting
Phase
Sponsor Loyola Marymount University
Condition Substance Use
Study Type INTERVENTIONAL
Enrollment 1,410 participants
Start Date 2025-07-09
Primary Completion 2026-07

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Pink CloudActive Control

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 1,410 participants in total. It began in 2025-07-09 with a primary completion date of 2026-07.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This randomized controlled trial (RCT) will evaluate the feasibility and efficacy of Pink Cloud, a mobile health application designed to support recovery from substance and alcohol use disorders (SUD/AUD). The app provides access to over 245,000 in-person and virtual 12-Step meetings, along with features such as a sobriety counter, daily planner, and personal inventory tools. In this study, 1,410 participants in various stages of recovery will be randomly assigned to receive either access to the Pink Cloud app or to a control condition. Participants will complete follow-up assessments at 1, 3, and 6 months. Primary outcomes include number of days sober and frequency of drug and alcohol problems. Secondary outcomes include meeting attendance, proportion of sober individuals in one's social network, and engagement in recovery-related activities. The investigators hypothesize that participants in the Pink Cloud group will report more days sober and fewer substance use problems than those in the control group, and that they will also report attending more meetings, having a greater proportion of sober peers, and engaging more frequently in recovery activities.

Eligibility Criteria

Inclusion Criteria: * Participant is 18 years of age or older * Participant is willing to attend a 12-Step or peer-to-peer recovery meeting (in person or virtual) within the next week * Participant owns a personal smartphone with cellular service * Participant is a permanent resident of the United States * Participant feels comfortable reading and understanding written English in everyday situations * Participant has consumed alcohol and/or used drugs (excluding tobacco or prescribed medication) at some point in their life, but not within the past couple of days * Participant is not currently attending outpatient or residential treatment for substance and/or alcohol use * Participant does not have a plan to enter substance and/or alcohol treatment in the next 30 days * Participant has been invited by the research team to either the intervention or control condition and redeemed their subscription code. * Informed consent is provided Exclusion Criteria: * Participant is younger than 18 years of age * Participant is unwilling to attend a 12-Step or peer-to-peer recovery meeting (in person or virtual) within the next week * Participant does not own a personal smartphone with cellular service * Participant is not a permanent resident of the United States * Participant does not feel comfortable reading and understanding written English in everyday situations * Participant has consumed alcohol or used drugs (excluding tobacco or prescribed medication) within the past couple of days * Participant has never consumed alcohol or used drugs * Participant is currently attending outpatient or residential treatment for substance and/or alcohol use * Participant has a plan to enter substance and/or alcohol treatment in the next 30 days * Participant was not invited by the research team or did not redeem their assigned subscription code * Informed consent is not provided

Contact & Investigator

Central Contact

Joseph LaBrie, Ph.D.

✉ jlabrie@lmu.edu

📞 3103385238

Frequently Asked Questions

Who can join the NCT07042451 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Substance Use. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07042451 currently recruiting?

Yes, NCT07042451 is actively recruiting participants. Contact the research team at jlabrie@lmu.edu for enrollment information.

Where is the NCT07042451 trial being conducted?

This trial is being conducted at Los Angeles, United States.

Who is sponsoring the NCT07042451 clinical trial?

NCT07042451 is sponsored by Loyola Marymount University. The trial plans to enroll 1,410 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology